(S)-(+)-Dimethindene maleate: Technical Guidance for Research Workflows

What This Product Solves

(S)-(+)-Dimethindene maleate (CAS 136152-65-3) is a small molecule antagonist with high selectivity for the muscarinic acetylcholine receptor subtype M2, while showing substantially reduced affinity for M1, M3, and M4 receptors. Its additional antagonism at the histamine H1 receptor expands its utility for dissecting overlapping pathways in autonomic regulation research, cardiovascular physiology studies, and respiratory system function research. Researchers working to delineate muscarinic acetylcholine receptor signaling pathways or evaluate receptor selectivity in pharmacological models will find this compound especially useful for isolating M2-specific effects and minimizing off-target muscarinic activity. This product is not intended for diagnostic or medical use.

For a broader discussion on integrating (S)-(+)-Dimethindene maleate into receptor selectivity workflows, see the article (S)-(+)-Dimethindene maleate: Selective M2 Muscarinic Ant..., which details experimental strategies for autonomic and cardiovascular studies. For practical guidance on assay setup and troubleshooting, consult (S)-(+)-Dimethindene maleate in Cell Assays: Practical Q&....

Protocol Parameters

• Stock solution preparation | ≥20.45 mg/mL (in water) | Preparation of concentrated stock for in vitro use | Ensures full dissolution and enables accurate dosing for cell-based or biochemical assays; do not exceed solubility limit or use incompatible solvents. | product_spec [product_url]
• Storage (solid form) | Room temperature, desiccated | Short- and medium-term bench storage | Maintains compound integrity and prevents hydrolysis or degradation under standard laboratory conditions. | product_spec [product_url]
• Solution stability | Use immediately after preparation; avoid long-term storage | All aqueous and buffered solution-based workflows | Compound stability is limited in solution; prompt use minimizes risk of degradation and preserves pharmacological activity. | product_spec [product_url]
• Assay working concentration | User-optimized, typically 1–100 µM* | Functional studies in receptor signaling, cell viability, or pathway interrogation | Final assay concentrations are not product-specified and should be empirically determined based on cell type, receptor expression, and control responses. | workflow_recommendation

*Empirical determination required. Refer to analogous M2 antagonist protocols for initial titration, adjusting as needed for specific experimental endpoints.

Workflow Setup and QC Checklist

• Confirm receipt of solid (S)-(+)-Dimethindene maleate with ≥98% purity as specified by APExBIO. Physically inspect for discoloration or moisture ingress.
• Prepare fresh stock solutions in sterile water at concentrations ≤20.45 mg/mL. Vortex or gently agitate to ensure complete dissolution.
• Minimize freeze-thaw cycles by aliquoting freshly prepared stock if multiple experiments are planned for the same day.
• Use stock solutions immediately; do not store aqueous solutions for future use due to limited stability.
• Record batch number and preparation details in laboratory notebook for traceability.
• Validate functional antagonism via appropriate positive controls (e.g., known M2 agonist challenge) before proceeding to main experimental endpoints.
• Dispose of unused or degraded solutions in accordance with institutional chemical waste protocols.

Common Failure Modes and Fixes

• Incomplete dissolution at high concentrations: If precipitation occurs, reduce concentration or increase mixing time. Avoid using organic solvents unless validated for your specific assay.
• Loss of activity in stored solutions: Activity loss is likely due to compound degradation in aqueous solution. Always prepare fresh stock prior to use; do not freeze-thaw repeatedly.
• Unexpected off-target effects: Verify that observed effects are not due to high concentrations or batch contamination. Include appropriate negative/vehicle controls to rule out non-specific responses.
• Reduced selectivity in complex biological systems: As selectivity is based on receptor subtype affinity, confirm target expression profiles and consider orthogonal readouts to distinguish M2-specific from H1-mediated effects.

Scope and Limitations

• (S)-(+)-Dimethindene maleate is validated for selective antagonism at M2 muscarinic and H1 histamine receptors; effects on other muscarinic subtypes (M1, M3, M4) are substantially reduced but not fully absent. Application outside these pathways should be empirically validated.
• The compound is best suited for in vitro and ex vivo research in autonomic regulation, cardiovascular, and respiratory models. In vivo use and translational relevance require further validation.
• Long-term solution storage is not supported by product specifications; stability and activity cannot be guaranteed beyond immediate use.
• Not for diagnostic or therapeutic use; strictly intended for controlled scientific research.

Conclusion

(S)-(+)-Dimethindene maleate provides a technically robust, selective tool for interrogating M2 muscarinic receptor function and H1 histamine pathways in controlled research settings. When handled according to product specifications—including preparation, storage, and assay integration—researchers can expect reproducible results for pharmacological profiling, autonomic regulation research, and cardiovascular physiology studies. For detailed product information and ordering, visit (S)-(+)-Dimethindene maleate at APExBIO.